Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Rochester Medical Corporation Over the Proposed Sale of the Company to C. R. Bard, Inc.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Rochester Medical Corporation (“Rochester” or the “Company”) (NasdaqGM: ROCM) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to C. R. Bard, Inc. (NYSE: BCR) in a cash deal valued at $262 million. Under the terms of the proposed transaction, Rochester’s stockholders will receive $20 for each share of Rochester common stock they own.
If you own common stock in Rochester and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Juan E. Monteverde
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.